Epidemiology & Risk Factors

  • Intranasal substance abuse: Cocaine (potent vasoconstriction → local ischemia, necrosis, and chondrocyte death).
  • Trauma & Iatrogenic:
    • Prior nasal surgery (septoplasty, rhinoplasty).
    • Repeated bilateral chemical/cautery for epistaxis.
    • Digital trauma (chronic nose picking) or foreign bodies.
    • Prolonged nasotracheal intubation or bilateral nasal packing.
  • Systemic inflammatory / Vasculitides:
    • Granulomatosis with polyangiitis (GPA) (most common rheumatologic cause).
    • SLE, Behçet disease, Sarcoidosis.
  • Infections:
    • Syphilis (tertiary gumma), Tuberculosis, Leishmaniasis.
    • Invasive fungal sinusitis (Mucor, Aspergillus) in immunocompromised/DKA.
  • Malignancy: Extranodal NK/T-cell lymphoma (nasal type), Squamous cell carcinoma (SCC).
  • Medications / Toxins: Chronic topical decongestants (oxymetazoline), nasal steroid overuse, occupational exposure (chromium, nickel, arsenic).

Clinical Features

  • Key History:
    • Whistling noise during nasal breathing (classic buzzword for small anterior perforations). c
    • Recurrent epistaxis and persistent dry crusting.
    • Sensation of nasal obstruction or fullness despite anatomical defect (due to disturbed laminar airflow).
    • Rhinorrhea, foul-smelling nasal discharge, or facial pain.
  • Physical Examination:
    • Anterior rhinoscopy/endoscopy: Defect visible in the cartilaginous septum (most frequently at the Kiesselbach plexus / Little’s area).
    • Mucosal borders: Friable, erythematous, ulcerated, or encrusted.
    • External inspection: Loss of dorsal support leading to saddle-nose deformity (depressed nasal dorsum).

Diagnosis

  • Initial Step:
    • Anterior rhinoscopy or flexible nasal endoscopy: Direct visualization of the perforation site, size, and mucosal edge characteristics.
  • Etiologic Workup:
    • Urine toxicology screen (UDS): Rapid screen for cocaine metabolites (benzoylecgonine).
    • Key Labs:
      • c-ANCA / PR3-ANCA: Elevated in GPA.
      • ANA, ESR/CRP: Evaluation for SLE and active systemic inflammation.
      • RPR / VDRL, QuantiFERON-TB: Rule out chronic infectious granulomas.
  • Imaging:
    • CT maxillofacial / paranasal sinuses: Assesses extent of cartilaginous/bony destruction and evaluates for invasive skull base or sinus pathology.
  • Confirmatory / Tissue Biopsy:
    • Biopsy of mucosal edges: Indicated for non-traumatic, unexplained, progressive, or atypical lesions.
    • Differentiates necrotizing vasculitis (GPA) from malignancy (NK/T-cell lymphoma, SCC) and fungal invasion.

Differential Diagnostics

  • Granulomatosis with Polyangiitis (GPA):
    • Differentiated by (+) PR3-ANCA / c-ANCA, pulmonary nodules/cavitations, and glomerulonephritis (hematuria, RBC casts).
  • Cocaine-Induced Midline Destructive Lesion (CIMDL):
    • Differentiated by (+) UDS, absence of systemic pulmonary/renal disease, and atypical p-ANCA (anti-human neutrophil elastase).
  • Extranodal NK/T-cell Lymphoma (Nasal Type):
    • Differentiated by rapidly progressive destructive midfacial lesion, biopsy showing EBV-positive atypical lymphoid infiltrate with angiocentric invasion.
  • Invasive Fungal Sinusitis (Mucormycosis):
    • Differentiated by acute, fulminant course in DKA or severe neutropenia, black necrotic eschar on turbinates/palate, and broad non-septate hyphae with 90° branching.
  • Tertiary Syphilis (Nasal Gumma):
    • Differentiated by positive treponemal/nontreponemal serologies, painless gummatous destruction, and history of untreated syphilis.

Management

  • First-line (Medical & Conservative):
    • Nasal hygiene: Aggressive saline nasal irrigations, humidification, and petroleum-based or antibiotic ointments (e.g., mupirocin) to minimize crusting and epistaxis.
    • Eliminate offending agent: Immediate cessation of cocaine, nasal decongestants, and digital trauma.
    • Targeted systemic therapy: Treat underlying autoimmune disease (e.g., glucocorticoids + rituximab/cyclophosphamide for GPA).
  • Second-line (Prosthetic Closure):
    • Silicone septal button (obturator):
      • Indicated for symptomatic patients who are poor surgical candidates, have persistent substance abuse, or have active systemic autoimmune disease.
      • Provides immediate reduction of whistling, crusting, and bleeding.
  • Refractory / Definitive Surgical Repair:
    • Surgical closure: Mucoperichondrial advancement flaps with interposition grafts (e.g., temporalis fascia, autologous cartilage).
    • Indications: Persistent severe symptoms, failed medical/prosthetic therapy.
    • Prerequisites: Must be disease-free (autoimmune quiescent) and strictly cocaine-free for at least 6–12 months prior to surgery to prevent flap necrosis.

Complications

  • Saddle-nose deformity (loss of anterior dorsal septal cartilage support).
  • Recurrent life-threatening epistaxis from exposed, friable mucosal margins.
  • Chronic atrophic rhinitis with secondary recalcitrant bacterial colonization (S. aureus, Klebsiella ozaenae).
  • Complete nasal airway obstruction secondary to large crust accumulation and structural collapse.